IGC Pharma Financial Overview
IGC Pharma's market cap is currently $28.16M. The company's EPS TTM is $-0.02; its P/E ratio is -3.89; IGC Pharma is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
